Achieving Appropriate Access to High Quality Care for the Treatment of Primary Immunodeficiency
Reserve your spot today for the Satellite Breakfast Symposium

Jointly provided by Postgraduate Institute for Medicine, the Immune Deficiency Foundation and Impact Education, LLC.
Postgraduate Institute for Medicine     Immune Deficiency Foundation     Impact Education, LLC
This activity is supported by an independent educational grant from CSL Behring.
Wednesday, October 12, 2022
6:00 AM - 6:30 AM - Registration and Breakfast
6:30 AM - 8:00 AM - Program
Gaylord National Harbor
Room: National Harbor 10
National Harbor, MD

Please note: Registration for AMCP Nexus 2022 is NOT required to attend this symposium.

Click here to download the slides from this symposium.

If you attended this symposium and need to complete an evaluation or claim credit, click here and register or login. Type in 17369 at the top of the page under "Find Post-Test/Evaluation by Course". Complete the online evaluation and obtain your certificate to download and/or print for your files.
  Learn About
  • Therapeutic options for primary immunodeficiency (PI)
  • The adverse effects of excess cost-sharing on patient access and adherence
  • Medical and pharmacy benefit design strategies that improve access to therapy
  Expert Faculty Presenters
Blachy J. Dávila Saldaña, MD
Attending Physician, Division of Blood and Marrow Transplantation
Director, Combined Immunodeficiency BMT Clinic
Fellowship Director, Bone Marrow Transplant and Cell Therapy
Children's National Hospital
Associate Professor of Pediatrics
George Washington University School of Medicine and Health Sciences
James Kenney, RPh, MBA
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.

  Statement of Need/Program Overview

Primary immunodeficiency (PI) affects >500,000 people in the United States, with a significant proportion of individuals with milder immune system defects suspected as not being formally diagnosed. The occult nature of PI symptoms and an overwhelming cache of potential differential diagnoses result in frequently delayed diagnoses and misdiagnoses, culminating in a lack of access to effective treatment and worsening outcomes. Rapid growth within PI’s diagnostic and therapeutic space is coupled with distinctly higher claims among patients whose diagnosis and appropriate treatment are delayed. These challenges are compounded for managed care professionals managing rising healthcare expenditures and the specialty drug trend. By instituting applicable coverage criteria, these stakeholders can improve the recognition and management of PI within their plan populations and ultimately impact total costs.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Describe the potential signs and symptoms of primary immunodeficiency (PI) in addition to predominant screening and diagnostic modalities
  • Assess available therapeutic options for PI based on disease type and patient characteristics
  • Characterize the adverse effect of excess cost-sharing on and prohibitive coverage criteria on patient access and adherence
  • Implement medical and pharmacy benefit design strategies that improve access to therapy and manage costs with evidence-based clinical care for PI

Date and Time
Wednesday, October 12, 2022
6:00 AM - 6:30 AM - Registration and Breakfast
6:30 AM - 8:00 AM - Program
Gaylord National Harbor
Room: National Harbor 10
National Harbor, MD

6:00 AM Registration and Breakfast
6:30 AM Pre-Activity Learning Assessment and Opening Comments
James Kenney, RPh, MBA
6:35 AM Clinical Overview of Primary Immunodeficiency: Signs, Symptoms, Screening, and Diagnostic Modalities
Blachy J. Dávila Saldaña, MD
7:00 AM Optimizing Treatment Selection and Dosing for PI based on Disease Type and Patient Characteristics
James Kenney, RPh, MBA
7:25 AM Medical and Pharmacy Management Strategies to Enhance PI Patient Outcomes in a Managed Care Setting (case-based presentation)
James Kenney, RPh, MBA
7:40 AM Audience Q&A Session
7:55 AM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
8:00 AM Adjournment
  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, Impact Education, LLC and the Immune Deficiency Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-22-351-L01-P
Type of Activity: Knowledge

For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Please note: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: Registration for AMCP Nexus 2022 is NOT required to attend this symposium.

Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email